← Evidence map

ReviewFrontiers in pharmacology2026

Targeting phosphofructokinase in cancer: integrating natural products for metabolic reprogramming and therapeutic innovation.

Chengjian Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42358350